Stability of parenteral midazolam in an oral formulation.
Midazolam is increasingly being used for oral sedation in pediatric dentistry. Unfortunately, it is available only as a parenteral formulation in Canada and the United States. Preparation of the parenteral solution for oral use is not uniform and leads the clinician to question the stability of this drug when used in conjunction with these vehicles. Therefore, the purpose of this study was to investigate the chemical stability of parenteral midazolam as an oral formulation to determine its expiry date. This was evaluated using a validated stability-indicating liquid chromatographic method. Midazolam was diluted in orange-flavored syrup to yield concentrations of 0.35, 0.64, and 1.03 mg/ml and then stored at room temperature. Samples were drawn on each of 9 study days (0, 1, 2, 6, 7, 9, 13, 21, and 102) and chromatographed. On each study day, solutions were inspected visually for changes in color, clarity, and appearance of particulate matter. Midazolam concentrations were considered within acceptable limits if they were not less than 90% of the initial concentration. Over the 102-day study period, there was no significant change in concentration in any of the solutions. On day 102, the remaining midazolam was within 7% of the day zero concentration. Therefore, these formulations of midazolam are stable at room temperature for a period of 102 days and would be suitable for clinical use.
Walker
S E
SE
Department of Pharmacy, Sunnybrook Health Science Centre, Toronto, Ontario, Canada.
Grad
H A
HA
Haas
D A
DA
Mayer
A
A
D000284:Administration, Oral; D018686:Anesthetics, Intravenous / Q000008:administration & dosage / Q000032:analysis / Q000737:chemistry*; D002626:Chemistry, Pharmaceutical; D002853:Chromatography, Liquid; D004355:Drug Stability; D004356:Drug Storage; D006863:Hydrogen-Ion Concentration; D007263:Infusions, Parenteral; D008874:Midazolam / Q000008:administration & dosage / Q000032:analysis / Q000737:chemistry*; D013997:Time Factors
D018686:Anesthetics, Intravenous; D008874:Midazolam